Literature DB >> 35525247

Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.

Nathan E Reticker-Flynn1, Weiruo Zhang2, Julia A Belk3, Pamela A Basto4, Nichole K Escalante3, Genay O W Pilarowski3, Alborz Bejnood2, Maria M Martins3, Justin A Kenkel3, Ian L Linde3, Sreya Bagchi3, Robert Yuan3, Serena Chang5, Matthew H Spitzer6, Yaron Carmi7, Jiahan Cheng3, Lorna L Tolentino3, Okmi Choi3, Nancy Wu3, Christina S Kong8, Andrew J Gentles9, John B Sunwoo10, Ansuman T Satpathy11, Sylvia K Plevritis12, Edgar G Engleman13.   

Abstract

For many solid malignancies, lymph node (LN) involvement represents a harbinger of distant metastatic disease and, therefore, an important prognostic factor. Beyond its utility as a biomarker, whether and how LN metastasis plays an active role in shaping distant metastasis remains an open question. Here, we develop a syngeneic melanoma mouse model of LN metastasis to investigate how tumors spread to LNs and whether LN colonization influences metastasis to distant tissues. We show that an epigenetically instilled tumor-intrinsic interferon response program confers enhanced LN metastatic potential by enabling the evasion of NK cells and promoting LN colonization. LN metastases resist T cell-mediated cytotoxicity, induce antigen-specific regulatory T cells, and generate tumor-specific immune tolerance that subsequently facilitates distant tumor colonization. These effects extend to human cancers and other murine cancer models, implicating a conserved systemic mechanism by which malignancies spread to distant organs.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ISGs; MHC-I; NK cells; PD-L1; Tregs; interferon; lymph nodes; metastasis; regulatory T cells; tolerance

Mesh:

Year:  2022        PMID: 35525247      PMCID: PMC9149144          DOI: 10.1016/j.cell.2022.04.019

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  116 in total

Review 1.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.

Authors:  Stanley P L Leong; Markus Zuber; Robert L Ferris; Yuko Kitagawa; Ramon Cabanas; Charles Levenback; Mark Faries; Sukamal Saha
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

3.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

4.  Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.

Authors:  Mojgan Ahmadzadeh; Anna Pasetto; Li Jia; Drew C Deniger; Sanja Stevanović; Paul F Robbins; Steven A Rosenberg
Journal:  Sci Immunol       Date:  2019-01-11

5.  TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.

Authors:  Daniele V F Tauriello; Sergio Palomo-Ponce; Diana Stork; Antonio Berenguer-Llergo; Jordi Badia-Ramentol; Mar Iglesias; Marta Sevillano; Sales Ibiza; Adrià Cañellas; Xavier Hernando-Momblona; Daniel Byrom; Joan A Matarin; Alexandre Calon; Elisa I Rivas; Angel R Nebreda; Antoni Riera; Camille Stephan-Otto Attolini; Eduard Batlle
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

6.  Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Authors:  Hélène Salmon; Juliana Idoyaga; Adeeb Rahman; Marylène Leboeuf; Romain Remark; Stefan Jordan; Maria Casanova-Acebes; Makhzuna Khudoynazarova; Judith Agudo; Navpreet Tung; Svetoslav Chakarov; Christina Rivera; Brandon Hogstad; Marcus Bosenberg; Daigo Hashimoto; Sacha Gnjatic; Nina Bhardwaj; Anna Karolina Palucka; Brian D Brown; Joshua Brody; Florent Ginhoux; Miriam Merad
Journal:  Immunity       Date:  2016-04-19       Impact factor: 31.745

7.  The chromatin accessibility landscape of primary human cancers.

Authors:  M Ryan Corces; Jeffrey M Granja; Shadi Shams; Bryan H Louie; Jose A Seoane; Wanding Zhou; Tiago C Silva; Clarice Groeneveld; Christopher K Wong; Seung Woo Cho; Ansuman T Satpathy; Maxwell R Mumbach; Katherine A Hoadley; A Gordon Robertson; Nathan C Sheffield; Ina Felau; Mauro A A Castro; Benjamin P Berman; Louis M Staudt; Jean C Zenklusen; Peter W Laird; Christina Curtis; William J Greenleaf; Howard Y Chang
Journal:  Science       Date:  2018-10-26       Impact factor: 63.714

8.  QuPath: Open source software for digital pathology image analysis.

Authors:  Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

9.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

10.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

View more
  11 in total

1.  Promise of hypoxia-targeted tracers in metastatic lymph node imaging.

Authors:  Shreya Goel; Sixiang Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-22       Impact factor: 10.057

2.  Nodal interferon exposure drives tumour-specific tolerance.

Authors:  Caroline Barranco
Journal:  Nat Rev Cancer       Date:  2022-07       Impact factor: 69.800

3.  Lymph nodes tolerate tumours.

Authors:  Lucy Bird
Journal:  Nat Rev Immunol       Date:  2022-07       Impact factor: 108.555

4.  An unexpected protein aggregate in diseased and ageing brains.

Authors:  Hideyuki Takahashi; Stephen M Strittmatter
Journal:  Nature       Date:  2022-05       Impact factor: 69.504

Review 5.  Reprogramming of sentinel lymph node microenvironment during tumor metastasis.

Authors:  Yen-Liang Li; Wen-Chun Hung
Journal:  J Biomed Sci       Date:  2022-10-20       Impact factor: 12.771

Review 6.  Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Authors:  Goodwin G Jinesh; Andrew S Brohl
Journal:  Signal Transduct Target Ther       Date:  2022-08-23

7.  Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma.

Authors:  Lu Pei; Qingfeng Zhu; Xiaoping Zhuang; Honglian Ruan; Zhiguang Zhao; Haide Qin; Qiongqiong Lin
Journal:  Transl Oncol       Date:  2022-07-08       Impact factor: 4.803

8.  Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p.

Authors:  Tianhang Li; Hongqian Guo; Rong Yang
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

9.  Higher Rate of Lymphedema with Inguinal versus Axillary Complete Lymph Node Dissection for Melanoma: A Potential Target for Immediate Lymphatic Reconstruction?

Authors:  Melina Deban; Patrick Vallance; Evan Jost; J Gregory McKinnon; Claire Temple-Oberle
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

10.  Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity.

Authors:  Daniel Heudobler; Lina Ghibelli; Albrecht Reichle
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.